Evidence map›Paper›PMID 37820031›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe.

Laura Kolberg, Aakash Khanijau, Fabian J S van der Velden, Jethro Herberg, Tisham De, Rachel Galassini, Aubrey J Cunnington, Victoria J Wright, Priyen Shah, Myrsini Kaforou and 28 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Role of biomarkers in pediatric sepsis: What evidence says?World journal of clinical pediatrics · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 12 countries.

Laura KolbergDr. von Hauner Children's Hospital, Division Pediatric Infectious Diseases, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-3311-8254
Aakash KhanijauDepartment of Infectious Diseases, Alder Hey Children's Hospital, Liverpool, United Kingdom.ORCID 0000-0003-2633-7157
Fabian J S van der VeldenPediatric Immunology, Infectious Diseases & Allergy Department, Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0001-7864-4074
Jethro HerbergSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Tisham DeSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-7278-0534
Rachel GalassiniSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-1025-0367
Aubrey J CunningtonSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-1305-3529
Victoria J WrightSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-7826-1516
Priyen ShahSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-9164-8862
Myrsini KaforouSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-9878-4007
Clare WilsonSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Taco KuijpersAmsterdam University Medical Center, Location Academic Medical Center, Department of Pediatric Immunology, Rheumatology and Infectious Diseases, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-7421-3370
Federico Martinón-TorresTranslational Pediatrics and Infectious Diseases, Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, Spain.ORCID 0000-0002-9023-581X
Irene Rivero-CalleTranslational Pediatrics and Infectious Diseases, Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, Spain.ORCID 0000-0002-3678-9264
Henriette MollDepartment of General Pediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0001-9304-3322
Clementien VermontDepartment of General Pediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-9196-6710
Marko PokornUniverzitetni Klinični Center, Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.ORCID 0000-0002-2341-2791
Mojca KolnikUniversity Medical Center Ljubljana, University Children's Hospital, Ljubljana, Slovenia.ORCID 0000-0003-4194-7295
Andrew J PollardOxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom.
Philipp K A AgyemanDepartment of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-8339-5444
Luregn J SchlapbachDepartment of Intensive Care and Neonatology, and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-2281-2598
Maria N TsoliaSecond Department of Pediatrics, Children's Hospital 'P. and A. Kyriakou,' National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0003-2485-4409
Shunmay YeungClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-0997-0850
Dace ZavadskaChildren Clinical University Hospital, Department of Pediatrics, Rīgas Stradina Universitāte, Riga, Latvia.
Werner ZenzDepartment of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Graz, Austria.ORCID 0000-0002-6218-3143
Nina A SchweintzgerDepartment of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Graz, Austria.ORCID 0000-0003-2549-5911
Michiel van der FlierPediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-1296-0159
Ronald de GrootPediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
Effua UsufMedical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Marie VoiceMicropathology Ltd, The Venture Center, University of Warwick Science Park, Coventry, United Kingdom.
Leonides Calvo-BadoMicropathology Ltd, The Venture Center, University of Warwick Science Park, Coventry, United Kingdom.
François MalletJoint Research Unit Hospice Civils de Lyon-bioMérieux, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Katy FidlerAcademic Department of Pediatrics, Royal Alexandra Children's Hospital, Brighton, United Kingdom.
Michael LevinSection of Pediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-2767-6919
Enitan D CarrolDepartment of Infectious Diseases, Alder Hey Children's Hospital, Liverpool, United Kingdom.ORCID 0000-0001-8357-7726
Marieke EmontsPediatric Immunology, Infectious Diseases & Allergy Department, Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0002-2822-3527
Ulrich von BothDr. von Hauner Children's Hospital, Division Pediatric Infectious Diseases, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-8411-1071
PERFORM Consortium
Imperial College London · GBComplejo Hospitalario Universitario de Santiago · ESRadboud University Nijmegen · NLLjubljana University Medical Centre · SINewcastle upon Tyne Hospital · GBUniversity of Liverpool · GBErasmus MC - Sophia Children’s Hospital · NLMedical University of Graz · ATGreat North Children's Hospital · GBLMU Klinikum · DENational and Kapodistrian University of Athens · GRUniversity of Warwick Science Park · GBChildren's Clinical University Hospital · LVGerman Center for Infection Research · DEUniversity of Bern · CHAmsterdam UMC Location University of Amsterdam · NLBrighton and Sussex Medical School · GBHôpital Lyon Sud · FRLondon School of Hygiene & Tropical Medicine · GBUniversity Children's Hospital Zurich · CH

Funding

Wellcome TrustWellcome Trust 203928/Z/16/Z
6 · The paper itself

Abstract

backgroundOptimization of antimicrobial stewardship is key to tackling antimicrobial resistance, which is exacerbated by overprescription of antibiotics in pediatric emergency departments (EDs). We described patterns of empiric antibiotic use in European EDs and characterized appropriateness and consistency of prescribing.

methodsBetween August 2016 and December 2019, febrile children attending EDs in 9 European countries with suspected infection were recruited into the PERFORM (Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management) study. Empiric systemic antibiotic use was determined in view of assigned final "bacterial" or "viral" phenotype. Antibiotics were classified according to the World Health Organization (WHO) AWaRe classification.

resultsOf 2130 febrile episodes (excluding children with nonbacterial/nonviral phenotypes), 1549 (72.7%) were assigned a bacterial and 581 (27.3%) a viral phenotype. A total of 1318 of 1549 episodes (85.1%) with a bacterial and 269 of 581 (46.3%) with a viral phenotype received empiric systemic antibiotics (in the first 2 days of admission). Of those, the majority (87.8% in the bacterial and 87.0% in the viral group) received parenteral antibiotics. The top 3 antibiotics prescribed were third-generation cephalosporins, penicillins, and penicillin/β-lactamase inhibitor combinations. Of those treated with empiric systemic antibiotics in the viral group, 216 of 269 (80.3%) received ≥1 antibiotic in the "Watch" category.

conclusionsDifferentiating bacterial from viral etiology in febrile illness on initial ED presentation remains challenging, resulting in a substantial overprescription of antibiotics. A significant proportion of patients with a viral phenotype received systemic antibiotics, predominantly classified as WHO Watch. Rapid and accurate point-of-care tests in the ED differentiating between bacterial and viral etiology could significantly improve antimicrobial stewardship.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipChildDrug PrescriptionsEmergency Service, HospitalEuropeFeverHumansPenicillinsAnti-Bacterial AgentsPenicillinsantibiotic prescriptionantimicrobial stewardshipAWaReinfectious diseasespediatric emergency care

Identifiers

PMID37820031
PMCPMC10954344
OpenAlexW4387520955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.